Evidence map›Paper›PMID 42443414›Full record

ArticleLeukemia2026

Lifelong phylogenetic reconstruction of immune-mediated clonal trajectories in paroxysmal nocturnal hemoglobinuria.

Hiroyuki Takamori, Yasutaka Ueda, Yoshikazu Matsuoka, Tatsuya Fujioka, Nozomi Yusa, Kazuaki Yokoyama, Hideki Makishima, Yoshiko Murakami, Taroh Kinoshita, Seiya Imoto and 6 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Leukemia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Hiroyuki TakamoriDepartment of Hematology and Oncology, The University of Osaka Graduate School of Medicine, Osaka, Japan.ORCID http://orcid.org/0000-0002-0179-3335
Yasutaka UedaDepartment of Hematology and Oncology, The University of Osaka Graduate School of Medicine, Osaka, Japan.ORCID http://orcid.org/0000-0003-1562-1013
Yoshikazu MatsuokaDepartment of iPS Stem Cell Regenerative Medicine, Kansai Medical University, Osaka, Japan.
Tatsuya FujiokaDepartment of iPS Stem Cell Regenerative Medicine, Kansai Medical University, Osaka, Japan.ORCID http://orcid.org/0000-0002-8168-6360
Nozomi YusaDepartment of Laboratory Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Kazuaki YokoyamaDepartment of Hematology and Oncology, The Institute of Medical Science Research Hospital, The University of Tokyo, Tokyo, Japan.
Hideki MakishimaDepartment of Hematology and Medical Oncology, Shinshu University School of Medicine, Matsumoto, Japan.ORCID http://orcid.org/0000-0001-5983-8578
Yoshiko MurakamiLaboratory of Immunoglycobiology, Research Institute for Microbial Diseases, The University of Osaka, Osaka, Japan.
Taroh KinoshitaLaboratory of Immunoglycobiology, Research Institute for Microbial Diseases, The University of Osaka, Osaka, Japan.ORCID http://orcid.org/0000-0001-7166-7257
Seiya ImotoDivision of Health Medical Intelligence, Human Genome Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Satoru MiyanoM&D Data Science Center, IIR, Institute of Science Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0002-1753-6616
Yuzuru KanakuraDepartment of Hematology and Oncology, The University of Osaka Graduate School of Medicine, Osaka, Japan.
Jun-Ichi NishimuraDepartment of Hematology and Oncology, The University of Osaka Graduate School of Medicine, Osaka, Japan.
Naoki HosenDepartment of Hematology and Oncology, The University of Osaka Graduate School of Medicine, Osaka, Japan.ORCID http://orcid.org/0000-0001-9570-0947
Seishi OgawaDepartment of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.ORCID http://orcid.org/0000-0002-7778-5374
Yasuhito NannyaDivision of Hematopoietic Disease Control, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. ynanya@ims.u-tokyo.ac.jp.ORCID http://orcid.org/0000-0002-6526-0992

Funding

Japan Agency for Medical Research and Development (AMED) 22ck0106691h0002Japan Agency for Medical Research and Development (AMED) 24ck0106875h0002Japan Agency for Medical Research and Development (AMED) 24tk0124003h0002
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42443414

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.